Sort
78,016 grants matching “breast cancer”
Synthetic introns for selective targeting of RNA splicing factor-mutant leukemia
$748,641Robert K Bradley · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
Program for the Elimination of Cancer Disparities (PECAD)
$748,578Graham A Colditz · Washington University · U54 · FY2014 · CA
Role of Novel Cytokine-like Molecule Secretoglobin (SCGB) 3A2 in Lung
$748,540Shioko Kimura · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Ligo-miR - A Multiplex Assay Platform for Targeted miRNA Profiling
$748,515Kelvin Liu · Circulomics, Inc. · R44 · FY2016 · GM
Genetic Epidemiology
$748,488Alisa Goldstein · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA
IND-Enabling Studies of ZB716, an Orally Bioavailable SERD
$748,371Guangdi Wang · Zenopharm, Llc · R44 · FY2018 · CA
VALIDATION AND QUANTIFICATION OF FFPE ANTIGEN RETRIEVAL BY PROTEOME ANALYSIS
$748,362Satya Prakash Saxena · Calibrant Biosystems, Inc. · R42 · FY2008 · CA
PyroTIMER Technology: Enabling T-Cell Persistence in Immunosuppressive Tumor Microenvironments
$748,337Archis Bagati · Pyrojas Inc · R44 · FY2024 · CA
DNA Sequencing and Digital Gene Expression Core
$748,221Kathleen Hartman · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA
Northwest Community Clinical Oncology Program
$748,188Yoshio Inoue · Tacoma General Hospital · U10 · FY2011 · CA
Randomized trial of REVITALIZE: A telehealth intervention to reduce fatigue interference among adults with advanced ovarian cancer on PARP inhibitors
$748,174Alexi A Wright · Dana-Farber Cancer Inst · R01 · FY2024 · CA
Privacy-Aware Federated Learning for Breast Cancer Risk Assessment
$748,154Spyridon Bakas · Indiana University Indianapolis · U24 · FY2023 · CA
Functional Proteomics of Breast Cancer
$748,144Harvard University (Medical School) · R33 · FY2005 · CA
HSV1 ONCOLYSIS-IMMUNE CHECKPOINT INHIBITION THERAPY FOR BREAST CANCER MENINGEAL METASTASES
$748,007The General Hospital Corporation · · FY2020 · Department of the Army
Using a SMART design to evaluate remotely delivered, culturally tailored weight loss interventions among Latina breast cancer survivors
$747,975Heather A Greenlee · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
Cancer Genomics Technology Development
$747,717Paul S. Meltzer · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Multimarker Risk Prediction in Cancer Therapy Cardiotoxicity
$747,668Bonnie Ky · University Of Pennsylvania · R01 · FY2015 · HL
ILLINOIS ONCOLOGY RESEARCH ASSOCIATION CCOP
$747,611Methodist Medical Center Of Illinois · U10 · FY2002 · CA
Targeting Slc16a/Mct Lactate Transporters in Cancer Therapeutics
$747,603John L. Cleveland · Scripps Florida · R01 · FY2014 · CA
Iowa Oncology Research Association
$747,553Robert J. Behrens · Iowa Oncology Research Association · U10 · FY2013 · CA
Onco-primary care networking to support TEAM-based care - the ONE TEAM Study
$747,552Kevin Charles Oeffinger · Duke University · R01 · FY2024 · CA
ELUCIDATING POLYMERASE THETA FUNCTIONS AND GENETIC DETERMINANTS OF SYNTHETIC LETHALITY IN BREAST CANCER
$747,312University Of North Carolina At Chapel Hill · · FY2018 · Department of the Army
Rewiring of regulatory networks in breast cancer by transcription factor isoforms
$747,298Marc Vidal · Dana-Farber Cancer Inst · U01 · FY2018 · CA
TEXAS CANCER GENETICS CONSORTIUM
$747,214University Of Texas Md Anderson Can Ctr · U24 · FY2004 · CA
Sentinel Node Versus Axillary Dissection in Breast Cancer
$747,145David N Krag · University Of Vermont & St Agric College · R01 · FY2010 · CA